Compare Recursion Pharmaceuticals Inc (RXRX) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Suncor Energy Inc. — how do they compare? Recursion Pharmaceuticals Inc trades at $4.36 (market cap $2.14B), while Suncor Energy Inc. trades at $72.23 (market cap $82.76B). The key difference: Suncor Energy Inc. is far larger — about 38.7× Recursion Pharmaceuticals Inc's market cap, and Suncor Energy Inc. pays a 2.39% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Recursion Pharmaceuticals Inc for 23 Days and Suncor Energy Inc. for 57 Days on average.
| RXRX | SU | |
|---|---|---|
Market Cap | $2.14B | $82.76B |
Volume | 30,789,535 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $6.79 | $71.87 |
52-Week Low | $2.84 | $38.17 |
Typical Hold Time | 23 Days | 57 Days |
Enterprise Value | $1.66B | $89.29B |
Dividend Yield | — | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RXRX trades at $4.36, up 2.11% today, with technical indicators showing a bullish trend. The company reported Q3 2026 revenue of $54 million but continues to post significant losses with a -961.97% net income margin. Recent strategic partnerships with Tempus and Roche are expanding its AI-driven drug pipeline, though the stock faces high short interest and substantial cash burn from operations.
The outlook remains speculative given persistent losses and high valuation multiples (P/S 37.14), but analyst consensus leans positive with 40% buy ratings. Key risks include execution on drug development timelines and dependence on financing activities to fund operations. Upside potential hinges on successful clinical milestones from its expanding pipeline.
Suncor Energy (SU) trades at $70.91, up 4.07% today and near its 52-week high. The stock shows a bullish technical trend with strong moving average signals, though the RSI indicates potential overbought conditions. Fundamentally, SU exhibits solid profitability with a 14.7% net income margin and attractive valuation ratios, including a P/E of 13.46. Recent news highlights asset sales and leadership transitions, while analyst sentiment remains overwhelmingly positive.
The outlook for SU is favorable, driven by robust cash flow, shareholder returns, and projected earnings growth. Key opportunities include its integrated model and geographic diversification. Risks involve commodity price volatility, operational challenges, and regulatory pressures. With no sell ratings from analysts and strong institutional support, the stock presents a compelling case for growth-oriented investors mindful of sector cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
